ARCHIVES

NCI Critic Epstein Resurfaces TO Blast ‘Cancer Establishment’

This article is from The Cancer Letter archive.

Vol. 18 No. 07 | February 14, 1992

Download PDF Visit The Full Archive

Related Articles

Litton Sells Clinical Labs, Planning to Join Recompetition For FCRF Contracts

July 12, 1985

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

Guest Opinion: Long Island Study’s Value Now Rests In Its Repository

November 2, 2002

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011